1Tara MW,Hugh M.Acamprosate:a new tool in the battle against alcohol dependence[J].Neuropsychiatric Dis Treat,2006,2(4):445-453.
2Walker RD,Howard MO,Lamber MD,et al.Psychiatric and medical comorbidities of veterans with substance use disorders[J].Hosp Community Psychiatry,1994,45(3):232-237.
3Anton RF,Kranzler HR,Meyer RE.Neurobehavioral aspects of the pharmacotherapy of alcohol dependence[J].Clin Neurosci,1995,3(3):145-154.
4Verheul R,van den Brink W,Geerlings P.A three-pathway psychobiological model of craving for alcohol[J].Alcohol Alcohol,1999,34(2):197-222.
5Boothby LA,Doering PL.Acamprosate for the treatment of alcohol dependence[J].Clin Ther,2005,27(6):695-714.
6Mark TL,Kassed CA,Vandivort-Warren R,et al.Alcohol and opioid dependence medications:prescription trends,overall and by physician specialty[J].Drug Alcohol Depend,2009,99(1-3):345-349.
7Spanagel R,Zieglgansberger W.Anti-craving compounds for ethanol:new pharmacological tools to study addictive processes[J].Trends Pharmacol Sci,1997,18(2):54-59.
8Cano-Cebrián MJ,Zornoza-Sabina T,Guerri C.Local acamprosate modulates dopamine release in the rat nucleusaccumbens through NMDA receptors:an in vivo microdialysis study[J].Naunyn Schmiedebergs Arch Pharmacol,2003,367(2):119-125.
9Harris BR,Prendergast MA,Gibson DA,et al.Acamprosate inhibits the binding and neurotoxic effects of trans-ACPD,suggesting a novel site of action at metabotropic glutamate receptors[J].Alcohol Clinl Exper Res,2002,26(12):1779-1793.
10Knpfel T,Zeise ML,Cuénod M,et al.L-homocysteic acid but not L-glutamate is an endogenous N-methyl-D-aspartic acid receptor preferring agonist in rat neocotical neurons in vitro[J].Neurosci Lett,1987,81(1-2):188-192.
9Walker RD, Howard MO, Lamber MD, et al. Psychiatric and medical comorbidities of veterans with substance use disorders [ J ]. Hosp community Psychiatry, 1994, 45 (3) : 232 - 237.
